CD36 and atherosclerosis: The significant predicted alteration in the atherosclerosis-related LXR/RXR activation pathway (–log(p-value) = 4.62, Z-score 2.3), including two upregulated scavenger receptors, MSR1 and CD36, also known as scavenger receptor A1 (SR-A1) and scavenger receptor B2 (SR-B2), respectively, regulates a range of pathways influencing both atherosclerosis initiation and progression [25].